Metal binding sheds light on mechanisms of amyloid assembly

References

• York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 1996; 14:369 - 396
   PubMed Web of Science ®Google Scholar
• Floege J, Ehlerding G. Beta-2-microglobulin-associated amyloidosis. Nephron 1996; 72:9 - 26
   PubMedGoogle Scholar
• Okon M, Bray P, Vucelic D. 1H NMR assignments and secondary structure of human beta 2-microglobulin in solution. Biochemistry 1992; 31:8906 - 8915
   PubMed Web of Science ®Google Scholar
• Morgan CJ, Gelfand M, Atreya C, Miranker AD. Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. J Mol Biol 2001; 309:339 - 345
   PubMed Web of Science ®Google Scholar
• Kameda A, Hoshino M, Higurashi T, Takahashi S, Naiki H, Goto Y. Nuclear magnetic resonance characterization of the refolding intermediate of beta(2)-microglobulin trapped by non-native prolyl peptide bond. J Mol Biol 2005; 348:383 - 397
   PubMed Web of Science ®Google Scholar
• Jahn TR, Parker MJ, Homans SW, Radford SE. Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol 2006; 13:195 - 201
   PubMed Web of Science ®Google Scholar
• Chiti F, Mangione P, Andreola A, Giorgetti S, Stefani M, Dobson CM, et al. Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. J Mol Biol 2001; 307:379 - 391
   PubMed Web of Science ®Google Scholar
• Malaguarnera M, Restuccia S, Di Fazio I, Zoccolo AM, Trovato BA, Pistone G. Serum beta2-microglobulin in chronic hepatitis C. Dig Dis Sci 1997; 42:762 - 766
   PubMed Web of Science ®Google Scholar
• Keating MJ. Chronic lymphocytic leukemia. Semin Oncol 1999; 26:107 - 114
   PubMed Web of Science ®Google Scholar
• Eakin CM, Attenello FJ, Morgan CJ, Miranker AD. Oligomeric assembly of native-like precursors precedes amyloid formation by beta-2 microglobulin. Biochemistry 2004; 43:7808 - 7815
   PubMed Web of Science ®Google Scholar
• Esposito G, Michelutti R, Verdone G, Viglino P, Hernandez H, Robinson CV, et al. Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci 2000; 9:831 - 845
   PubMed Web of Science ®Google Scholar
• McParland VJ, Kad NM, Kalverda AP, Brown A, Kirwin-Jones P, Hunter MG, et al. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. Biochemistry 2000; 39:8735 - 8746
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Hasegawa K, Yamaguchi I, Tsutsumi S, Kardos J, Goto Y, et al. Low concentrations of sodium dodecyl sulfate induce the extension of beta(2)-microglobulinrelated amyloid fibrils at a neutral pH. Biochemistry 2004; 43:11075 - 11082
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Yamaguchi I, Hasegawa K, Tsutsumi S, Goto Y, Gejyo F, et al. Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. J Am Soc Nephrol 2004; 15:126 - 133
   PubMed Web of Science ®Google Scholar
• Vorbeck-Meister I, Sommer R, Vorbeck F, Horl WH. Quality of water used for haemodialysis: bacteriological and chemical parameters. Nephrol Dial Transplant 1999; 14:666 - 675
   PubMed Web of Science ®Google Scholar
• Eakin CM, Knight JD, Morgan CJ, Gelfand MA, Miranker AD. Formation of a copper specific binding site in non-native states of beta-2-microglobulin. Biochemistry 2002; 41:10646 - 10656
   PubMed Web of Science ®Google Scholar
• Verdone G, Corazza A, Viglino P, Pettirossi F, Giorgetti S, Mangione P, et al. The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci 2002; 11:487 - 499
   PubMed Web of Science ®Google Scholar
• Villanueva J, Hoshino M, Katou H, Kardos J, Hasegawa K, Naiki H, et al. Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis. Protein Sci 2004; 13:797 - 809
   PubMed Web of Science ®Google Scholar
• Lim J, Vachet RW. Using mass spectrometry to study copper-protein binding under native and non-native conditions: beta-2-microglobulin. Anal Chem 2004; 76:3498 - 3504
   PubMed Web of Science ®Google Scholar
• Eakin CM, Berman AJ, Miranker AD. A native to amyloidogenic transition regulated by a backbone trigger. Nat Struct Mol Biol 2006; 13:202 - 208
   PubMed Web of Science ®Google Scholar
• Dobson CM. An accidental breach of a protein's natural defenses. Nat Struct Mol Biol 2006; 13:295 - 297
   PubMed Web of Science ®Google Scholar
• LeVine H 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 1993; 2:404 - 410
   PubMed Web of Science ®Google Scholar
• Calabrese MF, Miranker AD. Formation of a stable oligomer of beta-2 microglobulin requires only transient encounter with Cu(II). J Mol Biol 2007; 367:1 - 7
   PubMed Web of Science ®Google Scholar
• Antwi K, Mahar M, Srikanth R, Olbris MR, Tyson JF, Vachet RW. Cu(II) organizes {beta}-2-microglobulin oligomers but is released upon amyloid formation. Protein Sci 2008; 17:748 - 759
   PubMed Web of Science ®Google Scholar
• Calabrese MF, Eakin CM, Wang JM, Miranker AD. A regulatable switch mediates self-association in an immunoglobulin fold. Nat Struct Mol Biol 2008; 15:965 - 971
   PubMed Web of Science ®Google Scholar
• Burns CS, Aronoff-Spencer E, Dunham CM, Lario P, Avdievich NI, Antholine WE, et al. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry 2002; 41:3991 - 4001
   PubMed Web of Science ®Google Scholar
• McParland VJ, Kalverda AP, Homans SW, Radford SE. Structural properties of an amyloid precursor of beta(2)-microglobulin. Nat Struct Biol 2002; 9:326 - 331
   PubMedGoogle Scholar
• Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, et al. The cellular prion protein binds copper in vivo. Nature 1997; 390:684 - 687
   PubMed Web of Science ®Google Scholar
• Brown DR, Schmidt B, Kretzschmar HA. Effects of copper on survival of prion protein knockout neurons and glia. J Neurochem 1998; 70:1686 - 1693
   PubMed Web of Science ®Google Scholar
• Millhauser GL. Copper and the prion protein: methods, structures, function, and disease. Annu Rev Phys Chem 2007; 58:299 - 320
   PubMed Web of Science ®Google Scholar
• Viles JH, Klewpatinond M, Nadal RC. Copper and the structural biology of the prion protein. Biochem Soc Trans 2008; 36:1288 - 1292
   PubMed Web of Science ®Google Scholar
• Kenward AG, Bartolotti LJ, Burns CS. Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein. Biochemistry 2007; 46:4261 - 4271
   PubMed Web of Science ®Google Scholar
• Wadsworth JD, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1999; 1:55 - 59
   PubMed Web of Science ®Google Scholar
• Bocharova OV, Breydo L, Salnikov VV, Baskakov IV. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry 2005; 44:6776 - 6787
   PubMed Web of Science ®Google Scholar
• Davies P, Brown DR. The chemistry of copper binding to PrP: is there sufficient evidence to elucidate a role for copper in protein function?. Biochem J 2008; 410:237 - 244
   PubMed Web of Science ®Google Scholar
• Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, Atwood CS, et al. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J Biol Chem 1999; 274:23223 - 23228
   PubMed Web of Science ®Google Scholar
• Bush AI, Tanzi RE. The galvanization of beta-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 2002; 99:7317 - 7319
   PubMed Web of Science ®Google Scholar
• Miura T, Suzuki K, Kohata N, Takeuchi H. Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 2000; 39:7024 - 7031
   PubMed Web of Science ®Google Scholar
• Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 2001; 276:44284 - 44296
   PubMed Web of Science ®Google Scholar
• Lee JC, Gray HB, Winkler JR. Copper(II) Binding to alpha-Synuclein, the Parkinson's Protein. J Am Chem Soc 2008;
   Google Scholar
• Davis DP, Gallo G, Vogen SM, Dul JL, Sciarretta KL, Kumar A, et al. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain. J Mol Biol 2001; 313:1021 - 1034
   PubMed Web of Science ®Google Scholar
• Sayre LM, Perry G, Smith MA. Redox metals and neurodegenerative disease. Curr Opin Chem Biol 1999; 3:220 - 225
   PubMed Web of Science ®Google Scholar
• Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329:506 - 512
   PubMed Web of Science ®Google Scholar